Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy–Naïve Women With Hormone Receptor–Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial Supported in part ...

First-line treatment for metastatic melanoma continues to focus on immunotherapy. Long-term data from the CheckMate 067 trial confirmed the superiority of nivolumab combined with ipilimumab ...

This trial is looking at adding SCIB1 or iSCIB1+ to nivolumab and ipilimumab for melanoma. It is also looking at adding SCIB1 to pembrolizumab for melanoma. It is for people whose melanoma has grown ...

During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed goals and barriers to treatment when using ...

Nivolumab was first evaluated in a ... regimens of pembrolizumab with chemotherapy in patients with ipilimumab-refractory advanced melanoma were presented (Ribas et al, 2014b).

Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

Immune checkpoint inhibitors used for melanoma include: Pembrolizumab (Keytruda) and nivolumab (Opdivo) — These block the protein PD-1, taking the brakes off your T cells and allowing these immune ...

More information: Huang R et al, Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in ...

U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for ...

Doctors use targeted cancer drugs or immunotherapy to treat melanoma that has spread elsewhere in the body such as the liver, lungs or bone (advanced cancer). Or to treat stage 3 melanoma that cannot ...